Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors Press Release Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private Equity…Certara2022 年 12 月 8 日
Therapeutic Proteins’ Drug-Drug Interactions: Updates & Challenges On-Demand Webinar 治疗蛋白质的药物间相互作用:最新情况与挑战 Therapeutic proteins (TP) - and more specifically monoclonal antibodies - are part of the therapeutic…Certara2022 年 12 月 5 日
Project Optimus: How to Prepare for Success Press Coverage Project Optimus: How to Prepare for Success For some time now, cancer drug developers have known “Project Optimus” and new dose optimization…Certara2022 年 11 月 28 日
The eCTD Submission Process: Tips and Tricks for Drug Development Success White Paper eCTD 提交流程:助力药物开发成功的技巧与诀窍 Our experts compiled the tips and best practices you need to know for a successful…Certara2022 年 11 月 22 日
Tips & Tricks for Data Management in Phoenix WinNonlin Blog Tips & Tricks for Data Management in Phoenix WinNonlin Learn some tips & tricks for the Data Wizard, a data management tool in Phoenix,…Certara2022 年 11 月 18 日
Tips to Use Phoenix WinNonlin More Efficiently Blog Tips to Use Phoenix WinNonlin More Efficiently Certara’s Phoenix™ Pharmacokinetic and Pharmacodynamic (PK/PD) Platform is the single, interoperable hub for sharing pre-clinical…Certara2022 年 11 月 7 日
The Role of PBPK Modeling & Simulation in Infants & Neonates Blog PBPK 在婴儿与新生儿药物中的应用价值 Many factors make it challenging to obtain adequate pediatric samples for use in drug development…Certara2022 年 11 月 4 日
Why you should select your drug formulation before starting clinical studies Blog 为何应在开始临床研究前选择药物制剂 药物开发者常急于推进发现流程以进入人体试验。Most are…Certara2022 年 10 月 28 日
Accelerating Market Access with Data-Driven Payer Engagement Press Coverage Accelerating Market Access with Data-Driven Payer Engagement Using data visualizations to improve access to payers. With the switch to more digital environments,…Certara2022 年 10 月 25 日
Applications of PBPK modelling for regulatory submissions: case studies involving DDIs, transporters and special populations On-Demand Webinar Applications of PBPK modelling for regulatory submissions: case studies involving DDIs, transporters and special populations Over the past two decades, there have been transformative changes in our approach to using…Certara2022 年 10 月 20 日